United Therapeutics Corporation
UTHR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,697 | $1,208 | $961 | $895 |
| Short-Term Investments | $1,570 | $1,786 | $1,878 | $1,036 |
| Receivables | $279 | $279 | $220 | $199 |
| Inventory | $158 | $112 | $102 | $94 |
| Other Curr. Assets | $170 | $166 | $219 | $100 |
| Total Curr. Assets | $3,874 | $3,551 | $3,380 | $2,324 |
| Property Plant & Equip (Net) | $1,222 | $1,045 | $862 | $781 |
| Goodwill | $32 | $34 | $28 | $28 |
| Intangibles | $80 | $81 | $17 | $17 |
| Long-Term Investments | $1,475 | $1,910 | $1,316 | $1,650 |
| Tax Assets | $458 | $395 | $328 | $262 |
| Other NC Assets | $222 | $152 | $114 | $108 |
| Total NC Assets | $3,490 | $3,616 | $2,664 | $2,846 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,364 | $7,167 | $6,045 | $5,169 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $4 | $4 |
| Short-Term Debt | $300 | $400 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $432 | $399 | $339 | $302 |
| Total Curr. Liab. | $738 | $804 | $343 | $305 |
| LT Debt | $0 | $300 | $800 | $800 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $182 | $78 | $105 | $105 |
| Total NC Liab. | $182 | $378 | $905 | $905 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $920 | $1,182 | $1,248 | $1,210 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $7,222 | $6,027 | $5,042 | $4,315 |
| AOCI | -$3 | -$13 | -$56 | -$23 |
| Other Equity | -$776 | -$30 | -$191 | -$334 |
| Total Equity | $6,444 | $5,985 | $4,797 | $3,959 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,364 | $7,167 | $6,045 | $5,169 |
| Net Debt | -$1,397 | -$508 | -$161 | -$95 |